Download Antimicrobial Pharmacodynamics Against MRSA in an in Vitro Infection Model Books PDF Free

Antimicrobial Pharmacodynamics Against MRSA in an in Vitro Infection Model PDF
By:Noha Alkurdi
Published on 2011 by

Methicillin-resistant S.aureus (MRSA) is a highly virulent pathogen associated with serious healthcare-associated (HCA-MRSA) and community-associated (CA-MRSA) infections. MRSA is an increasingly important cause of skin and skin-structure, bloodstream and other invasive infections including pneumonia and endocarditis. The pharmacodynamics of existing treatments and anovel cephalosporin with activity against MRSA were studied in an in vitro infection model comparing the antibacterial effects of monotherapy and combination therapy under standard and altered environmental conditions. The activity of monotherapy with vancomycin, daptomycin, linezolid and ceftobiprole against clinical MRSA isolates were tested along with combinations of vancomycin-ceftobiprole, daptomycin-ceftobiprole and linezolid-ceftobiprole. Antibacterial response under standard conditions supporting optimal bacterial growth were compared to altered conditions with acidic pH 5.5, diluted nutrient broth (1:2) and increased temperature 40°C. Two clinical isolates including one HCA-MRSA (#81655) and one CA-MRSA (#79002) were studied in an in vitro pharmacodynamic model (IPDM) over 24 hours. Clinical dosing regimens equivalent to vancomycin 1500 mg intravenously every 12 hours (peak =24.4 mg/L, trough =7.4 mg/L), daptomycin 6 mg/kg (420 mg) intravenously every 24 hours (peak =8.2 mg/L, trough =0.8 mg/L) and linezolid 600 mg intravenously every 12 hours (peak =9.2 mg/L, trough =2.8 mg/L) were tested. Ceftobiprole was administrated as a bolus dose followed by constant infusion of 10 mg/L. Antibacterial effects were quantified as initial bacterial kill rate over 4 hours (KR4) and absolute bacterial kill at 24 hours (BK24). Minimum inhibitory concentrations (MIC) were measured via E-test® methods using initial isolates and those recovered after 24 hours of therapy. The KR4 with daptomycin and vancomycin were equivalent (P=0.14), yet daptomycin was more rapid than ceftobiprole (P=0.03) and linezolid (P

This Book was ranked at 4 by Google Books for keyword Pharmacodynamics.

Book ID of Antimicrobial Pharmacodynamics Against MRSA in an in Vitro Infection Model's Books is gemKAQAACAAJ, Book which was written byNoha Alkurdihave ETAG "o6dcEBy7X5Y"

Book which was published by since 2011 have ISBNs, ISBN 13 Code is and ISBN 10 Code is

Reading Mode in Text Status is false and Reading Mode in Image Status is false

Book which have "166 Pages" is Printed at BOOK under Category

Book was written in en

eBook Version Availability Status at PDF is falseand in ePub is false

Book Preview

Download Antimicrobial Pharmacodynamics Against MRSA in an in Vitro Infection Model PDF Free

Download Antimicrobial Pharmacodynamics Against MRSA in an in Vitro Infection Model Books Free

Download Antimicrobial Pharmacodynamics Against MRSA in an in Vitro Infection Model Free

Download Antimicrobial Pharmacodynamics Against MRSA in an in Vitro Infection Model PDF

Download Antimicrobial Pharmacodynamics Against MRSA in an in Vitro Infection Model Books